Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
INKT — MiNK Therapeutics, Inc.
NASDAQ
FULL STOCK PAGE →

Q2 2026 Earnings Call Summary

AUG 13, 2026
REVENUE
$0
EPS
-$0.62 -8.8%
FREE CASH FLOW
-$2.08B -120113.3%

No summary has been written for this call yet.